ABIN1169196

antibody from antibodies-online

Targeting: IDO1 IDO, INDO

Western blot (Recommended by provider)

ELISA (Recommended by provider)

Flow cytometry (Recommended by provider)

Antibody Data

Product number

ABIN1169196

Provider

antibodies-online

Product name

anti-Indoleamine 2,3-Dioxygenase 1 (IDO1) antibody

Antibody type

Polyclonal

Antigen

Recombinant human IDO.

Reactivity

Human

Host

Rabbit

Vial size

100 μg

Concentration

1mg/ml

Storage

4°C

References

Submitted references

Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.

Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, Balsamo M, Conte R, Benelli R, Minghelli S, Solari N, Gualco M, Queirolo P, Moretta L, Mingari MC
Cancer research 2012 Mar 15;72(6):1407-15

---

The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.

Opitz CA, Litzenburger UM, Opitz U, Sahm F, Ochs K, Lutz C, Wick W, Platten M
PloS one 2011;6(5):e19823

---

Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.

Curti A, Trabanelli S, Onofri C, Aluigi M, Salvestrini V, Ocadlikova D, Evangelisti C, Rutella S, De Cristofaro R, Ottaviani E, Baccarani M, Lemoli RM
Haematologica 2010 Dec;95(12):2022-30

---

Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase.

Maby-El Hajjami H, Amé-Thomas P, Pangault C, Tribut O, DeVos J, Jean R, Bescher N, Monvoisin C, Dulong J, Lamy T, Fest T, Tarte K
Cancer research 2009 Apr 1;69(7):3228-37

---

HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.

Boasso A, Herbeuval JP, Hardy AW, Anderson SA, Dolan MJ, Fuchs D, Shearer GM
Blood 2007 Apr 15;109(8):3351-9